Sofosbuvir, velpatasvir, and voxilaprevir successful in patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence to direct-acting antiviral drug regimens.
Danielle Mroz
Advertisement
Articles by Danielle Mroz
People who inject drugs may still able to achieve a cure of hepatitis C virus infection with treatment with direct-acting antivirals.
Advertisement
Latest Updated Articles
Injection Drug Users With HCV Still Able to Achieve Viral RemissionPublished: November 12th 2018 | Updated:
HCV Combo Effective Treating Patients With HIV Coinfection After Disease RecurrencePublished: November 13th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Gedatolisib Triplet Shows Significant PFS Benefit in HR+/HER2– Breast Cancer
5
